Industry News (Disease Prevention)

Innovative Cancer and HIV Treatments in Development

Published in Vaccine Weekly, December 7th, 1998

Intravec Inc, Winston-Salem, North Carolina, announced that cancer and HIV treatment and prevention strategies may soon be available to patients.

IntraVec says it has built on research done at Wake Forest University School of Medicine by Si-Yi Chen, MD, PhD, a former assistant professor of cancer biology and now an associate professor at Baylor College of Medicine.

The cancer treatments use "toxic cell" technology in which Chen and his colleagues genetically modified normal cells to produce and secrete a toxin that attacks and kills cancer cells but does not harm the carrier cell or other normal cells.

Scientists see this...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-12-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry